CareFusion Company Profile (NYSE:CFN)

About CareFusion (NYSE:CFN)

CareFusion logoCareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:CFN
  • CUSIP: 14170T10
  • Web:
Average Prices:
  • 50 Day Moving Avg: $60.00
  • 200 Day Moving Avg: $59.00
  • 52 Week Range: $38.00 - $60.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 20.00
  • P/E Growth: 0
  • Net Margins: 16.18%
  • Return on Equity: 12.80%
  • Return on Assets: 7.62%
  • Average Volume: 2.71 million shs.
Frequently Asked Questions for CareFusion (NYSE:CFN)

What is CareFusion's stock symbol?

CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."

How were CareFusion's earnings last quarter?

CareFusion Co. (NYSE:CFN) released its quarterly earnings data on Thursday, February, 5th. The company reported $0.99 EPS for the quarter, topping analysts' consensus estimates of $0.79 by $0.20. The company earned $1.07 billion during the quarter, compared to the consensus estimate of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The firm's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the firm earned $0.54 EPS. View CareFusion's Earnings History.

Who are some of CareFusion's key competitors?

How do I buy CareFusion stock?

Shares of CareFusion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CareFusion's stock price today?

One share of CareFusion stock can currently be purchased for approximately $60.00.

MarketBeat Community Rating for CareFusion (NYSE CFN)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  125 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  271
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CareFusion (NYSE:CFN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for CareFusion (NYSE:CFN)
No equities research coverage for this company has been tracked by


Earnings History for CareFusion (NYSE:CFN)
Earnings by Quarter for CareFusion (NYSE:CFN)
Earnings History by Quarter for CareFusion (NYSE CFN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2015Q215$0.79$0.99$1.01 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$0.49$0.50$920.50 million$922.00 millionViewN/AView Earnings Details
8/7/2014Q414$0.72$0.79$1.04 billion$1.12 billionViewListenView Earnings Details
5/5/2014Q314$0.62$0.60$986.67 million$968.00 millionViewListenView Earnings Details
2/3/2014Q214$0.54$0.54$911.13 million$922.00 millionViewListenView Earnings Details
8/8/2013Q4 2013$0.56$0.55$918.25 million$903.00 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.53$0.59$909.16 million$901.00 millionViewListenView Earnings Details
8/9/2012$0.50$0.51ViewN/AView Earnings Details
5/3/2012$0.45$0.49ViewN/AView Earnings Details
2/2/2012$0.43$0.44ViewN/AView Earnings Details
11/7/2011$0.33$0.33ViewN/AView Earnings Details
8/8/2011$0.50$0.52ViewN/AView Earnings Details
5/5/2011$0.40$0.42ViewN/AView Earnings Details
2/3/2011$0.37$0.44ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CareFusion (NYSE:CFN)
Current Year EPS Consensus Estimate: $3 EPS
Next Year EPS Consensus Estimate: $3 EPS


Dividend History for CareFusion (NYSE:CFN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for CareFusion (NYSE:CFN)
Insider Trades by Quarter for CareFusion (NYSE:CFN)
Insider Trades by Quarter for CareFusion (NYSE:CFN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/6/2015Jonathan WygantCAOSell1,700$59.79$101,643.00View SEC Filing  
2/6/2015Philip L FrancisDirectorSell40,980$59.89$2,454,292.20View SEC Filing  
12/15/2014Thomas J LeonardInsiderSell25,000$58.87$1,471,750.00View SEC Filing  
12/4/2014Donald AbbeyEVPSell1,000$59.35$59,350.00View SEC Filing  
11/12/2014J Michael LoshDirectorSell12,630$57.32$723,951.60View SEC Filing  
10/6/2014James F HinrichsCFOSell20,000$56.91$1,138,200.00View SEC Filing  
10/6/2014Thomas J LeonardInsiderSell8,400$57.16$480,144.00View SEC Filing  
10/1/2014James F HinrichsCFOSell20,000$45.07$901,400.00View SEC Filing  
9/19/2014Thomas J LeonardInsiderSell16,600$47.01$780,366.00View SEC Filing  
9/15/2014Thomas J LeonardInsiderSell25,000$46.17$1,154,250.00View SEC Filing  
7/7/2014Thomas J LeonardInsiderSell1,250$45.47$56,837.50View SEC Filing  
7/1/2014Thomas J LeonardInsiderSell19,721$45.00$887,445.00View SEC Filing  
6/6/2014James F HinrichsCFOSell21,506$44.07$947,769.42View SEC Filing  
6/2/2014Thomas J LeonardInsiderSell1,250$42.81$53,512.50View SEC Filing  
5/29/2014Fortune Gordon LaEVPSell2,158$42.61$91,952.38View SEC Filing  
5/20/2014Kieran GallahueCEOSell100,000$42.98$4,298,000.00View SEC Filing  
5/19/2014Fortune Gordon LaEVPSell38,738$42.70$1,654,112.60View SEC Filing  
5/19/2014Thomas LeonardInsiderSell30,000$42.89$1,286,700.00View SEC Filing  
5/5/2014Thomas LeonardInsiderSell1,250$39.06$48,825.00View SEC Filing  
4/7/2014Thomas LeonardInsiderSell1,250$40.05$50,062.50View SEC Filing  
4/4/2014Donald AbbeyEVPSell10,076$41.79$421,076.04View SEC Filing  
3/3/2014Thomas LeonardInsiderSell1,250$40.26$50,325.00View SEC Filing  
2/5/2014Philip FrancisDirectorBuy6,500$38.61$250,965.00View SEC Filing  
2/5/2014Thomas LeonardInsiderSell21,496$38.24$822,007.04View SEC Filing  
1/9/2014Kieran GallahueCEOSell25,000$41.05$1,026,250.00View SEC Filing  
1/6/2014Thomas LeonardInsiderSell1,250$39.48$49,350.00View SEC Filing  
12/2/2013James HinrichsCFOSell28,078$40.13$1,126,770.14View SEC Filing  
12/2/2013Kieran GallahueCEOSell25,000$40.09$1,002,250.00View SEC Filing  
12/2/2013Thomas LeonardInsiderSell1,250$39.99$49,987.50View SEC Filing  
11/4/2013Thomas J LeonardInsiderSell1,250$39.06$48,825.00View SEC Filing  
10/1/2013Thomas J LeonardInsiderSell1,250$36.99$46,237.50View SEC Filing  
9/9/2013Fortune Gordon LaEVPSell33,960$36.55$1,241,238.00View SEC Filing  
9/3/2013Thomas LeonardInsiderSell1,250$35.70$44,625.00View SEC Filing  
8/26/2013J Michael LoshDirectorSell53,311$35.67$1,901,603.37View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CareFusion (NYSE:CFN)
Latest Headlines for CareFusion (NYSE:CFN)
DateHeadline logoMedical Tech Firm Becton Dickinson Agrees to Buy C.R. Bard For $24 Billion - April 24 at 9:40 AM logoSomewhat Critical News Coverage Extremely Likely to Impact CareFusion (CFN) Stock Price - April 14 at 7:52 AM logoBecton Dickinson Lifts Dividend by 11% - November 30 at 4:21 PM logo[$$] Becton Dickinson Could Pump Out Steady Gains - October 23 at 8:52 AM logoCompanies Reach 52-Week Highs - October 23 at 8:52 AM logoBecton Dickinson: 19% EPS Growth With Good Dividends - June 26 at 5:10 PM logoBearish Sentiment in Becton Dickinson's Stock - April 27 at 1:12 PM logoBecton, Dickinson: What I Will Be Looking Out For In Today's Results - February 3 at 11:55 AM logoBecton, Dickinson and Company’s 1Q16 Results: Major Influences - February 1 at 8:06 AM logoValuation Multiples: Becton, Dickinson and Company versus Peers - January 27 at 4:07 PM logoBecton Dickinson Has More Room To Grow; Argus Reiterates Buy Rating - January 7 at 9:42 AM logoBecton, Dickinson Hits 52-Week High on Portfolio Strength - December 17 at 10:20 AM logoBecton, Dickinson: FDA Nod for Vertebral Balloon Systems - December 11 at 2:35 PM logo[$$] Becton Dickinson Tops Expectations - November 4 at 1:43 PM logoCAREFUSION CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp - March 17 at 9:39 AM logoBecton Dickinson wins EU approval for $12 bln CareFusion buy - March 13 at 1:32 PM logoCareFusion beats Street 2Q forecasts - February 5 at 9:22 AM logoCareFusion tops Street 1Q forecasts - November 6 at 4:58 PM logoDollar surge puts Q4 earnings at risk and two-year stock uptrend in peril - October 8 at 8:25 AM logoUS STOCKS-Wall St gains, S&P edges above 50-day moving average - October 6 at 9:51 AM logoAhead of the Bell: Becton-Dickinson shares surge - October 6 at 9:27 AM logoUS STOCKS-HP, Becton Dickinson among biggest premarket movers - October 6 at 7:29 AM logoPRESS DIGEST- New York Times business news - Oct 6 - October 6 at 1:53 AM



CareFusion (CFN) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by Staff